-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ELNPedlr/r6iOR4r/geIfhsB+vQJMnjDI1cJ9zSOoQOGaGNZpLKEnuFnFiVlw6T/ R2e41Npcwk/3e8IsJPLvvw== 0000885988-01-500030.txt : 20010806 0000885988-01-500030.hdr.sgml : 20010806 ACCESSION NUMBER: 0000885988-01-500030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010801 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20010803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRAMED AMERICA INC CENTRAL INDEX KEY: 0000885988 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 061150326 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20260 FILM NUMBER: 1696585 BUSINESS ADDRESS: STREET 1: ONE MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 BUSINESS PHONE: 9142538000 MAIL ADDRESS: STREET 1: 1 MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 FORMER COMPANY: FORMER CONFORMED NAME: IVF AMERICA INC DATE OF NAME CHANGE: 19950720 8-K 1 secondqtr2001pressrel.txt INTEGRAMED AMERICA, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act 1934 Date of Report: August 1, 2001 INTEGRAMED AMERICA, INC. (Exact name of registrant as specified in charter) Delaware (State of other jurisdiction of incorporation) 0-20260 and 1-11440 06-1150326 - -------------------------------------------------------------------------------- (Commission File Numbers) (IRS Employer Identification No.) One Manhattanville Road, Purchase, NY 10577 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone no. including area code: (914) 253-8000 -------------- Registrant's former name: IVF America, Inc. ----------------- ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits Exhibit No. Description of Exhibit ----------- ---------------------- 99.5 Registrant's Press Release dated August 1, 2001 ITEM 9. Regulation FD disclosure Registrant's Press Release dated August 1, 2001 attached as Exhibit 99.5 hereto is furnished pursuant to Regulation FD; it is not filed. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INTEGRAMED AMERICA, INC. (Registrant) Date: August 1, 2001 By: /s/John W. Hlywak, Jr. ---------------------- John W. Hlywak, Jr. Sr. Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) EX-99 4 ex99.txt INTEGRAMED AMERICA, INC. John W. Hlywak, Jr. (investors) Jay Higham (media) Senior Vice President & CFO Senior Vice President Marketing IntegraMed America, Inc. IntegraMed America, Inc. (914) 251-4143 (914) 251-4127 Web Address: http://www.integramed.com INTEGRAMED REPORTS SECOND QUARTER RESULTS --EPS INCREASES 57% Purchase, NY, August 1, 2001 -- IntegraMed America, Inc. (Nasdaq: INMD) today announced financial results for the second quarter and first six months ended June 30, 2001. Revenues for the second quarter of 2001 were approximately $18.3 million, a 35.2% increase from the same period in 2000. The contribution to earnings from operations in the second quarter of 2001 was approximately $2.6 million compared to $2.1 million for the same period in 2000. Net income for the second quarter of 2001 was $406,000 compared to net income of $368,000 for the same period in 2000. Diluted earnings per share for the second quarter of 2001 were $0.12 compared to $0.08 for the same period in 2000. Revenues for the first six months of 2001 were $34.8 million, a 28.2% increase from the same period in 2000. The contribution to earnings from operations for the first six months of 2001 was approximately $5.0 million compared to $4.0 million for the same period in 2000. Net income for the first six months of 2001 was $765,000 compared to a net income of $658,000 for the same period in 2000. Diluted earnings per share for the first six months of 2000 were $0.22 compared to $0.14 for the same period in 2000. "Historically, the second quarter is one of our strong quarters in terms of demand for fertility services," said Gerardo Canet, President and CEO of IntegraMed America, Inc. "This year was no different. The core Business Services segment of our Company performed at record levels with same-center revenues growing by 27% during the quarter. In addition, our Pharmacy Services segment experienced 82.4% growth in revenues and 154% growth in contribution in the year to date period." "During the quarter, we also began enrolling patients in the Shared Risk Refund Program," added Mr. Canet. "Under this innovative financing program, fertility patients pay IntegraMed a fixed fee for up to three attempts at in vitro fertilization at an affiliated fertility center. This program is popular with consumers because it fixes the cost of treatment with the added benefit that a substantial refund is issued in the event that treatment is unsuccessful. The Program is also popular with physicians because it helps to keep patients in treatment longer, which promotes practice building and improved clinical outcomes. During the first quarter of 2001, we concentrated on building the infrastructure to support Shared Risk Refund. We are now actively recruiting patients at approximately half of the Company's affiliated fertility centers." IntegraMed, based in Purchase, NY, offers products and services to patients, providers, payors and manufacturers focused on the $2 billion infertility industry. Specifically, the Company provides Business Services to a network of Fertility Centers; distributes pharmaceutical products and financing programs directly to patients and, conducts clinical research through IntegraMed Research Institute. Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed America are forward-looking statements. Actual results may differ materially from the statements made as a result of various factors including, but not limited to, the risks associated with the Company's ability to finance future growth; the loss of significant management contract(s); profitability at Reproductive Science Centers managed by IntegraMed America; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the Company's most recent Form 10-K and in other documents filed by the Company with the U.S. Securities and Exchange Commission (SEC). INTEGRAMED AMERICA, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (all amounts in thousands, except per share amounts)
For the For the three-month period six -month period ended June 30, ended June 30, ------------------- ----------------- 2001 2000 2001 2000 ------- ------- ------ ------- (unaudited) (unaudited) Revenues, net ........................................ $18,287 $13,527 $34,778 $27,135 Cost of services incurred: Employee compensation and related expenses ........ 7,433 5,370 13,633 10,467 Direct materials .................................. 3,958 2,680 7,776 5,161 Occupancy costs ................................... 873 847 1,872 1,660 Depreciation ...................................... 300 345 574 679 Other expenses .................................... 3,116 2,206 5,969 5,119 ------- ------- ------- ------- Total cost of services .......................... 15,680 11,448 29,824 23,086 ------- ------- ------- ------- Network Sites' contribution .......................... 2,607 2,079 4,954 4,049 ------- ------- ------- ------- General and administrative expenses .................. 1,880 1,390 3,569 2,739 Amortization of intangible assets .................... 225 214 441 434 Interest expense/(income) ............................ 33 68 65 134 Income before income taxes ........................... 469 407 879 742 Provision for income taxes ........................... 63 39 114 84 ------- ------- ------- ------- Net income (loss) .................................... $ 406 $ 368 $ 765 $ 658 Less: Dividends paid and/or accrued on Preferred Stock 33 33 66 66 ------- ------- ------- ------- Net income (loss) applicable to Common Stock ......... $ 373 $ 335 $ 699 $ 592 ======= ======= ======= ======= Weighted average shares - basic ...................... 2,993 4,163 3,109 4,270 ======= ======= ======= ======= Weighted average shares - diluted .................... 3,105 4,226 3,150 4,334 ======= ======= ======= ======= Basic and diluted earnings per share of Common Stock . $ 0.12 $ 0.08 $ 0.22 $ 0.14 ======= ======= ======= ======= EBITDA ............................................... $ 1,135 $ 1,152 $ 2,173 $ 2,226 ======= ======= ======= =======
INTEGRAMED AMERICA, INC. CONSOLIDATED BALANCE SHEET (all amounts in thousands) June 30, 2001 December 31, 2000 ------------- ----------------- (unaudited) Total current assets......................... $17,788 $17,817 Total assets................................. 41,668 41,295 Total current liabilities.................... 15,246 12,874 Shareholders' equity......................... 24,560 25,987 Total liabilities and shareholders' equity... 41,668 41,295 -----END PRIVACY-ENHANCED MESSAGE-----